Medicare does not cover the Discseel procedure. There is no national or local Medicare coverage determination approving it, and both government health agencies and private insurers classify it as experimental and investigational. If you choose Discseel, expect to pay the full cost yourself, typically between $15,000 and $30,000.1Discseel. Discseel FAQs
Why Medicare Treats Discseel as Experimental
Discseel is a minimally invasive spinal procedure that injects fibrin sealant into damaged intervertebral discs. Fibrin products are FDA-approved for controlling bleeding during surgery, but injecting them into spinal discs is an off-label use that has not received regulatory clearance.2U.S. Department of Veterans Affairs. VHA Clinical Determination and Indication – Discseel (CDI-00059) Without FDA approval for this specific indication, Medicare has no basis to classify the procedure as “reasonable and necessary,” which is the standard it applies to decide what it pays for.
A December 2025 clinical determination from the Veterans Health Administration stated the position directly: there are no Medicare coverage determinations for Discseel, the procedure is considered investigational and experimental, and it is not medically necessary for chronic back pain associated with spinal disc conditions.2U.S. Department of Veterans Affairs. VHA Clinical Determination and Indication – Discseel (CDI-00059)
The clinical evidence sits behind that classification. The largest randomized, placebo-controlled trial of fibrin sealant disc injection, a Phase III study of 220 patients, found no statistically significant difference at six months between fibrin injections and saline; the trial was terminated and its results have not been published in the peer-reviewed literature.3ResearchGate. Intradiscal Injection of Fibrin Sealant – Prospective Multicenter Pilot Study A 2024 retrospective study of 827 patients reported improvements in pain and disability at one, two, and three years, but the authors acknowledged the need for randomized, double-blind controlled trials to confirm the findings.4Southwest Spine & Sports. Long-Term Investigation of Annulargrams and Intra-Annular Fibrin – Pain Physician 2024 The North American Spine Society’s 2020 guidelines found insufficient evidence to recommend for or against intradiscal biologic injections.5Arkansas Blue Cross Blue Shield. Intradiscal Injections Medical Policy
The Whole Category of Disc Injections Is Non-Covered
Discseel does not sit alone. In April 2025, the Medicare contractor Noridian Healthcare Solutions finalized a Local Coverage Determination establishing non-coverage for all intervertebral disc injections meant to rehydrate, repair, or supplement the disc for chronic low back pain.6Centers for Medicare & Medicaid Services. LCD for Intervertebral Disc Repair (L39960) The policy sweeps in gene therapies, growth factors, cellular-based injections, tissue-engineered constructs, platelet-rich plasma, and methylene blue injections. CMS reviewed the studies on these treatments and found the evidence insufficient. So even if Discseel were rebranded or bundled with a related biologic, the coverage answer would still be no.
Medicare Advantage and Medigap Will Not Fill the Gap
Medicare Advantage plans generally follow Original Medicare’s rules on experimental treatment. UnitedHealthcare’s Medicare Advantage policy, effective May 2025, states that experimental and investigational procedures are not considered reasonable and necessary and are not covered.7UnitedHealthcare. Experimental, Investigational and Clinical Trials – Medicare Advantage Policy Advantage plans will pay routine care costs for CMS-approved clinical trials, but Discseel is not part of any such trial. Medigap (Medicare Supplement) plans only pay cost-sharing on services Original Medicare already covers, so they offer no path to Discseel coverage either.
What You Would Actually Pay
Because roughly 90% of Discseel patients pay out of pocket, the price tag matters.8Arizona Center for Pain and Movement. Discseel Cost in Phoenix Estimates run from $15,000 to $30,000 depending on the provider, with additional charges for anesthesia, the annulogram imaging that precedes the injection, and facility fees. Some clinics offer financing, and the official Discseel site notes the procedure may be tax-deductible as a medical expense.1Discseel. Discseel FAQs
The procedure is available only through a restricted network of trained, certified providers. The official physician directory lists roughly 65 practice locations across 18 states, concentrated in Texas, Arizona, and Florida.9Discseel. Discseel Physician Directory
Back Pain Treatments Medicare Does Cover
Plenty of back pain care is covered. Under Part B, that includes physical therapy, occupational therapy, chiropractic spinal manipulation, acupuncture for chronic low back pain (up to 12 sessions in 90 days, extendable to 20 annually if improvement is documented), nerve blocks, radiofrequency ablation, and epidural steroid injections in certain settings.10Medicare.gov. Pain Management11UnitedHealthcare. Medicare Coverage for Back Pain Part B also covers chronic pain management services (monthly assessments, medication reviews, and care coordination) for pain lasting more than three months.
Surgical options are covered when medically necessary, generally after conservative treatments have failed. These include microdiscectomy or laminectomy, spinal fusion, spinal cord stimulation, and surgical implantation of artificial discs.11UnitedHealthcare. Medicare Coverage for Back Pain Prescription pain medications may be covered under Part D.
Could Medicare Cover Discseel in the Future?
Two things would have to happen. Either fibrin sealant would need FDA approval for use in spinal discs, or someone would need to petition CMS through the National Coverage Determination process with supporting clinical evidence.12Centers for Medicare & Medicaid Services. NCD Request Process CMS could also approve coverage under its Coverage with Evidence Development framework, but only if the procedure were performed within a CMS-approved clinical study.13Centers for Medicare & Medicaid Services. Lumbar Spinal Stenosis – Coverage with Evidence Development Given that the largest randomized trial showed no benefit over saline and closed without published results, the evidence gap that would need to close is significant. CMS has said it will consider new peer-reviewed literature through formal reconsideration if it is submitted.14Centers for Medicare & Medicaid Services. Response to Comments – Intervertebral Disc Repair (A60150)
If you are weighing Discseel now, the practical takeaway is that Medicare will not pay any portion of it and no supplement plan will bridge that gap. Ask your provider what covered treatments you have not yet tried, and get a written cost estimate before scheduling anything at a Discseel clinic.